Hjem › Major depresjon › Maryland
Kliniske studier for Major depresjon i Maryland
21 studier for Major depresjon søker deltakere på steder i Maryland.
Byer i Maryland
Offisiell studietekst (engelsk)
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 8 til 70 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05669703Natural History of Depression, Bipolar Disorder and Suicide Risk
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudie
Alder 18 til 120 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06462196A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
RekruttererFase 3
Alder 18 til 74 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07573176Characterization and Treatment of Adolescent Depression
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 11 til 25 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT03388606A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Delricht Research - Rockville, Rockville
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07621237A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Johns Hopkins University, Baltimore
RekruttererFase 3
Alder 12 til 17 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07227454A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Sunstone Medical, PC, Rockville
RekruttererFase 3
Alder 18 til 85 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06793397Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 65 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT03065335Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
- National Institutes of Health Clinical Center, Bethesda
- University of Maryland, College Park, College Park
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
Alder 8 til 65 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT00018057Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06511908Defining Neurobiological Links Between Substance Use and Mental Illness
- National Institute on Drug Abuse, Baltimore
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 til 60 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT05538910Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1
Alder 18 til 70 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT03973268Neurobiology of Suicide
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
Alder 18 til 70 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT02543983A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Pharmasite Research Inc., Baltimore
RekruttererFase 3
Alder 18 til 74 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Gaithersburg
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT07300969A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 6. aug. 2026 · NCT07412756A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Continental Clinical Solutions, Towson
RekruttererFase 2
Alder 18 til 64 · Alle kjønn · Oppdatert 27. jul. 2026 · NCT07115329Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Gaithersburg
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. jul. 2026 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Pikesville
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 24. jul. 2026 · NCT07484217A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Sheppard Pratt, Baltimore
- Sunstone Medical, PC, Rockville
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 11. mai 2026 · NCT06524830Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.